High Point Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.3K Buy
78
+8
+11% +$9.44K 0.07% 117
2026
Q2
$84K Hold
70
– – 0.07% 115
2026
Q1
$64.4K Buy
70
+15
+27% +$15.2K 0.06% 121
2025
Q4
$59.1K Buy
+55
New +$52.6K 0.06% 130

Other funds holding LLY

High Point Wealth Management's LLY Position: Q3 2026 in Review

High Point Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $9.44K and bringing the position to 78 shares worth $90.3K. The position accounts for 0.07% of the portfolio, ranked #117.

High Point Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • High Point Wealth Management held 78 shares of Eli Lilly worth $90.3K as of Q3 2026.
  • High Point Wealth Management bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
  • Eli Lilly made up 0.07% of High Point Wealth Management's portfolio in Q3 2026, its #117 holding.
  • High Point Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on High Point Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.